qx-222 has been researched along with proadifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrantes, GE; Ortells, MO | 1 |
| Benziane, B; Chibalin, AV; Heiny, JA; Kravtsova, VV; Krivoi, II; Mandel, F; Pedersen, SE; Prokofiev, AV; Radzyukevich, TL | 1 |
2 other study(ies) available for qx-222 and proadifen
| Article | Year |
|---|---|
Understanding channel blocking in the nicotinic acetylcholine receptor.
Topics: Acetylcholine; Animals; Binding Sites; Chlorisondamine; Ethidium; Hexamethonium; Lidocaine; Mice; Nicotinic Antagonists; Onium Compounds; Pempidine; Proadifen; Quinacrine; Receptors, Nicotinic; Trityl Compounds | 2001 |
The nicotinic acetylcholine receptor and the Na,K-ATPase alpha2 isoform interact to regulate membrane electrogenesis in skeletal muscle.
Topics: Animals; Caveolin 3; Dose-Response Relationship, Drug; Enzyme Inhibitors; Lidocaine; Male; Membrane Potentials; Membrane Proteins; Neuromuscular Junction; Nicotinic Agonists; Nicotinic Antagonists; Phosphoproteins; Proadifen; Protein Binding; Rats; Rats, Wistar; Receptors, Nicotinic; Sarcolemma; Sodium-Potassium-Exchanging ATPase; Torpedo | 2010 |